Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)

SHA:688488 Revenue

In the year 2025, Jiangsu Aidea Pharmaceutical Group had annual revenue of 720.67M CNY with 72.49% growth. Jiangsu Aidea Pharmaceutical Group had revenue of 168.27M in the quarter ending December 31, 2025, with 41.49% growth.

• Revenue: 720.67M
• Revenue Growth: +72.49%
• P/S Ratio: 9.89
• Revenue / Employee: 1.02M
• Employees: 683
• Market Cap: 7.13B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	720.67M	302.86M	72.49%
Dec 31, 2024	417.80M	6.44M	1.57%
Dec 31, 2023	411.36M	167.14M	68.44%
Dec 31, 2022	244.22M	-11.49M	-4.49%
Dec 31, 2021	255.71M	-33.35M	-11.54%